medication
FDA to rule on Novo’s CagriSema soon
The U.S. Food and Drug Administration is expected to issue its decision before the close of 2026 on whether to grant approval…
FDA approves new hepatitis B treatment
FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.
FDA Approves Tildrakizumab for Psoriatic Arthritis
The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use for moderate-to-severe plaque psoriasis.
AI Models Often Give Wrong Medication Doses
AI models give wrong medication doses in about 2% of cases, Doximity research finds, raising concerns about AI in healthcare.
Patients Stop Medication Due to Emotional, Identity Struggles
Patients stop medication due to emotional and identity struggles, revealing a complex reality beyond side effects or forgetfulness.
Subcutaneous Efgartigimod Improves Ocular Myasthenia Symptoms
Subcutaneous efgartigimod significantly improves ocular myasthenia symptoms, with III ADAPT OCULUS data showing less double vision and drooping eyelids.
Oral diabetes drug proves heart-safe in study
New oral diabetes drug orforglipron (Foundayo) proves heart-safe in study, meeting cardiovascular safety standards compared to insulin glargine.
Trump picks Overton to head FDA
President Trump appoints physician Heidi Overton as the new FDA commissioner to oversee drug approvals and health regulations.
Users Alarmed After Platform Announces Blocking Policy
Vitamin D deficiency linked to kidney disease affects bone health, blood pressure, immune function and survival, revealing a critical public health issue.
User access restricted after policy breach
The FDA approved Simtriyo, a new ADHD medication for adults and children, improving focus and emotional regulation with extended-release benefits.